Sebia – Updated HbA1c Meta-Analysis
Sebia is pleased to release the new edition HbA1c Meta-Analysis.
03Apr
03Apr
Sebia HbA1c
The Sebia HbA1c kit is designed for the separation and quantitation of the HbA1c glycosylated fraction of haemoglobin in human blood by capillary electrophoresis providing a high throughput method with clear-cut and precise results.
03Apr
New Publication: A Novel Approach to Estimating M-Protein Concentration: Capillary Electrophoresis Quantitative Immunosubtraction
Abacus dx and Sebia are pleased to advise you of a new publication:
03Apr
IDS-iSYS 17-OH Progesterone Assay
An automated assay for the quantitative determination of 17-OH Progesterone in human serum or plasma.
03Apr
IDS-iSYS 1,25 Vit D
Fully automated assay for the quantitative determination of 1,25-dihydroxyvitamin D [1,25(OH)2D] in human serum on the IDS-iSYS platform. The results are used in conjunction with other
01Apr
IDS-iSYS Free Testosterone
An automated assay for the quantitative determination of free testosterone in human serum or plasma. Measurement of testosterone is used in the diagnosis and treatment of disorders involving the male sex hormones (androgens), including primary and secondary hypogonadism, delayed or precocious puberty, impotence in males; in females hirsutism (excessive hair) and virilisation (masculinisation) due to tumours, polycystic ovaries, and adrenogenital syndromes.
01Apr
IDS Ostase BAP EIA for the quantitative measurement of bone-specific alkaline phosphatase
The Ostase® BAP EIA Immunoenzymetric Assay is an in vitro device indicated for the quantitative measurement of bone-specific alkaline phosphatase (BAP), an indicator of osteoblastic activity in human serum.
01Apr
Sero Autonorm Human Liquid – now available in three levels
In order to cover the needs for a clinical chemistry QC material at the low end of the reference range, SERO has developed Autonorm™ Human Liquid Low.
01Apr
Seronorm Cardiac Acute Liq Controls
Seronorm Cardiac Acute Liq is the most complete acute control on the market, combining the complete panel of cardiac markers and acute markers to rule out life threatening conditions such as sepsis, brain trauma, thrombosis and ectopic pregnancy.